The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
Razan MasarwyShahaf ShiloNarin Nard Carmel NeidermanLiyona KampelGilad HorowitzNidal MuhannaJoubran MansourPublished in: Cancers (2023)
The integration of 40-GEP with staging systems can improve the identification of cSCC patients at high risk of metastasis, potentially leading to improved care and outcomes, especially in the high-risk class 2B group.